09887.HK 財務： Nanjing Leads Biolabs Co., Ltd. AI 分析

Q: 技術分析指標如何適用於 09887.HK？

根據技術分析，Nanjing Leads Biolabs Co., Ltd. 的綜合信號為 Neutral。Nanjing Leads Biolabs Co., Ltd. 有 3 個買入信號，1 個中性信號和 3 個賣出信號。

Q: 09887.HK 的費波那契回檔水準是多少？

Nanjing Leads Biolabs Co., Ltd. 的費波那契回檔水準是 介於 23.6% 和 38.2% 之間。

Q: Nanjing Leads Biolabs Co., Ltd. 的 RSI 是多少？

Nanjing Leads Biolabs Co., Ltd. 的 RSI 目前為 67.87，表明處於 中立 狀態

Q: Nanjing Leads Biolabs Co., Ltd. 接下來 12 個月的價格是多少？

Nanjing Leads Biolabs Co., Ltd. 09887.HK 接下來 12 個月的價格預估為 $0。

Q: Nanjing Leads Biolabs Co., Ltd. 預計會漲到多高？

據華爾街分析師稱，Nanjing Leads Biolabs Co., Ltd. 預計將達到 $0 的高預測值。

首頁

股票

09887.HK

預測

LEADS BIOLABS-B (09887.HK)

Nanjing Leads Biolabs Co., Ltd.

HK$54

-1.18%

$-0.64

盤中： Jan 19, 15:24:15 HKT

關鍵數據

前收市價

$56.5

開盤價

$54.65

當日範圍

$53.95 - $54.65

52週區間

$44.72 - $83.6

交易量

88.9K

平均成交量

590.5K

每股盈餘 (TTM)

-1.70

股息收益率

市值

$8.2B

什麼是 LEADS BIOLABS-B？

Nanjing Leads Biolabs Co., Ltd. operates as a pharmaceutical company. The company is headquartered in Nanjing, Jiangsu and currently employs 192 full-time employees. The company went IPO on 2025-07-25. The Company’s main drug candidates include LBL-024, LBL-034, LBL-033, LBL-007 and others. The firm's LBL-024 is mainly used to treat extra-pulmonary neuroendocrine carcinoma (EP-NEC), small cell lung cancer (SCLC), biliary tract carcinoma (BTC), non-small-cell lung cancer (NSCLC), esophageal squamous cell carcinoma (ESCC), hepatocellular carcinoma (HCC), gastric cancer (GC) and other solid tumors. The firm has also developed multiple proprietary technology platforms, including LeadsBod platform (a CD3 T-cell engager platform), X-body platform (a 4-1BB engager platform) and several other bispecific antibody and fusion protein platforms. The firm mainly conducts its business in the domestic market.

功能特性

交易策略

資源

市場

09887.HK 股價預測摘要

09887.HK stock price ended at $56.5 on 星期五, after rising 1.44%

On the latest trading day Jan 16, 2026, the stock price of 09887.HK rose by 1.44%, climbing from $55.05 to $56.50. Throughout the session, the stock experienced a volatility of 3.91%, with prices fluctuating between a daily low of $55.00 and a high of $57.15. Alongside this price increase, trading volume also rose by 116.4K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 262.0K shares were traded, amounting to a market value of approximately $8.6B.

09887.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 1

賣出訊號 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

09887.HK 目前顯示 3 個買入訊號與 3 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 4.63%。整體而言，技術指標顯示中期後市趨勢為 Neutral。

09887.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為09887.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 09887.HK？



09887.HK 的費波那契回檔水準是多少？



Nanjing Leads Biolabs Co., Ltd. 的 RSI 是多少？



Nanjing Leads Biolabs Co., Ltd. 接下來 12 個月的價格是多少？



Nanjing Leads Biolabs Co., Ltd. 預計會漲到多高？



Nanjing Leads Biolabs Co., Ltd.（09887.HK）價格

09887.HK 股價走勢圖